Loading
Latest filing published 28 Jul 2017 for Athenex, Inc., €15k.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
J. Nick Riehle discloses dealings in 2 companies, chiefly Chelsea Therapeutics International, Ltd. and Athenex, Inc. We count 16 filings; the first trade dates from 25 September 2008 and the latest from 19 June 2017.
The open-market record is one-sided, with 6 purchases worth €33k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 8 option exercises. So far in 2017, the count stands at 1 purchase and no sales.
In size, the median ticket on the buying side is €3,019.
On 28 July 2017 came the latest disclosure, an open-market purchase for €15k in Athenex, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations